CCCC Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $2.95

Kapitalisasi Pasar (MRQ) $363M

P/E (TTM) -3.2

EPS (TTM) $-0.91

Pendapatan (TTM) $35M

ROE (TTM) -48.1%

Rentang 52M $2–$5

CCCC Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang C4 Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Wikidata ↗

sektorHealthcare industriBiotechnology karyawan104 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$36M

2021-12-31 → 2025-12-31

EPS$-1.27

2021-12-31 → 2025-12-31

Arus Kas Bebas$-99M

2020-12-31 → 2025-12-31

Margin bersih-289.4%

2022-12-31 → 2025-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	CCCC	rata-rata 5T	Median Rekan	Kesimpulan
P/E (TTM)	-3.2rata-rata 5T ≈-5.2	≈-5.2	·	·
P/S (TTM)	10.3rata-rata 5T ≈14.5	≈14.5	16.4	Nilai wajar
P/B (MRQ)	1.5rata-rata 5T ≈1.7	≈1.7	2.6	Nilai wajar
Harga / FCF (TTM)	-4.2rata-rata 5T ≈-5.9	≈-5.9	·	·
Harga / Arus Kas (TTM)	-4.3rata-rata 5T ≈-5.9	≈-5.9	·	·
Price / Tangible Book (Harga / Nilai Buku Berwujud)	1.1rata-rata 5T ≈1.7	≈1.7	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	CCCC	rata-rata 5T	Median Rekan	Kesimpulan
Margin Operasi (TTM)	-319.0%rata-rata 5T ≈-435.8%	≈-435.8%	-164.6%	Lemah
EBITDA Margin (Margin EBITDA)	-320.5%rata-rata 5T ≈-435.8%	≈-435.8%	-164.6%	Lemah
Pretax Margin (Margin Sebelum Pajak)	-291.7%rata-rata 5T ≈-406.5%	≈-406.5%	-135.6%	Lemah
Margin Laba Bersih (TTM)	-289.4%rata-rata 5T ≈-409.6%	≈-409.6%	-245.9%	Di bawah rata-rata
ROA (TTM)	-30.9%rata-rata 5T ≈-27.5%	≈-27.5%	-27.3%	Sejajar
ROE (TTM)	-48.1%rata-rata 5T ≈-43.1%	≈-43.1%	-21.3%	Di bawah rata-rata
ROIC	-45.0%rata-rata 5T ≈-52.5%	≈-52.5%	-45.8%	Sejajar

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	Tren 5 Tahun	CCCC	rata-rata 5T	Median Rekan	Kesimpulan
Rasio Lancar (MRQ)		5.4rata-rata 5T ≈6.5	≈6.5	5.4	Sejajar
Quick Ratio (Rasio Cepat)		2.3rata-rata 5T ≈2.7	≈2.7	2.7	Likuiditas rendah

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	Tren 5 Tahun	CCCC	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)		1.0%rata-rata 5T ≈1.8%	≈1.8%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)		5.0%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	CCCC	rata-rata 5T	Median Rekan	Kesimpulan
EPS (Diluted)	$-1.27rata-rata 5T ≈$-1.98	≈$-1.98	·	·
Revenue / Share (Pendapatan / Saham)	$0.43rata-rata 5T ≈$0.50	≈$0.50	·	·
Cash Flow / Share (Arus Kas / Saham)	$-1.19rata-rata 5T ≈$-1.61	≈$-1.61	·	·
Cash / Share (Kas / Saham)	$0.77rata-rata 5T ≈$1.16	≈$1.16	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	CCCC	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	0.1rata-rata 5T ≈0.1	≈0.1	0.2	Lemah
Receivables Turnover (Perputaran Piutang)	13.1rata-rata 5T ≈7.4	≈7.4	7.9	Tingkat teratas
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$345.6K	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 21.7%

Laporan Berikutnya Nov 04, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Agu 5, 2026	$-0.18	$-0.23	22.0%
31 Maret 2026		$-0.20	$-0.38	47.3%
31 Des. 2025		$-0.18	$-0.31	41.9%
30 Sep. 2025		$-0.44	$-0.41	-6.2%
30 Juni 2025		$-0.37	$-0.39	5.5%
31 Maret 2025		$-0.37	$-0.46	19.4%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 14

Metrik	2025	2024	2023	2022	2021
Revenue	$36M	$36M	$21M	$31M	$46M
R&D Expense	$104M	$111M	$118M	$118M	$95M
SG&A Expense	$36M	$42M	$42M	$43M	$33M
Operating Expenses	$151M	$155M	$160M	$161M	$128M
Operating Income	$-115M	$-120M	$-139M	$-130M	$-82M
Other Non-op	$10M	$14M	$8M	$1M	$-2M
Pretax Income	$-105M	$-105M	$-131M	$-128M	$-84M
Income Tax	$121.0K	$131.0K	$1M	$0	$0
Net Income	$-105M	$-105M	$-132M	$-128M	$-84M
EPS (Basic)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82
EPS (Diluted)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82
Shares (Basic)	82,894,459	69,372,993	49,640,505	48,861,665	46,041,733
Shares (Diluted)	82,894,459	69,372,993	49,640,505	48,861,665	46,041,733
EBITDA	$-115M	$-120M	$-139M	$-130M	$-82M

Neraca 22

Metrik	2025	2024	2023	2022	2021
Cash & Equivalents	$75M	$55M	$127M	$30M	$76M
Short-term Investments	·	·	·	·	$233M
Receivables	$2M	$3M	$12M	$1M	$6M
Prepaid Expense	$7M	$10M	$6M	$10M	$11M
Current Assets	$258M	$258M	$271M	$288M	$326M
PP&E (Net)	$5M	$6M	$7M	$7M	$3M
PP&E (Gross)	$16M	$15M	$15M	$16M	$10M
Accum. Depreciation	$11M	$9M	$8M	$8M	$7M
Other Non-current Assets	$4M	$3M	$3M	$2M	$544.0K
Total Assets	$359M	$350M	$376M	$431M	$507M
Accounts Payable	$858.0K	$1M	$1M	$1M	$5M
Current Liabilities	$33M	$45M	$43M	$45M	$51M
Capital Leases	$54M	$60M	$66M	$71M	$31M
Total Liabilities	$102M	$134M	$130M	$142M	$117M
Long-term Debt	·	·	$0	$11M	$11M
Total Debt	·	·	$0	$11M	$11M
Common Stock	$9.0K	$7.0K	$6.0K	$5.0K	$5.0K
Retained Earnings	$-739M	$-634M	$-528M	$-396M	$-268M
AOCI	$50.0K	$53.0K	$-127.0K	$-4M	$-775.0K
Stockholders' Equity	$257M	$216M	$246M	$289M	$390M
Liabilities + Equity	$359M	$350M	$376M	$431M	$507M
Shares Outstanding	96,914,418	70,625,899	60,467,188	48,966,216	48,688,875

Arus Kas 13

Metrik	2025	2024	2023	2022	2021
D&A	$2M	$2M	$2M	$2M	$1M
Stock-based Comp	$19M	$30M	$27M	$30M	$22M
Restructuring	$0	$2M	$0	·	·
Operating Cash Flow	$-99M	$-65M	$-107M	$-106M	$-87M
CapEx	$607.0K	$180.0K	$2M	$5M	$1M
Investing Cash Flow	$-9M	$-51M	$158M	$58M	$-189M
Stock Issued	·	·	$58M	$0	·
Stock Repurchased	$193.0K	$194.0K	$110.0K	$0	·
Net Stock Activity	$-193.0K	$-194.0K	$58M	·	·
Financing Cash Flow	$126M	$45M	$45M	$1M	$171M
Net Change in Cash	$19M	$-71M	$97M	$-46M	$-105M
Taxes Paid	$131.0K	$76.0K	·	·	·
Free Cash Flow	$-99M	$-65M	$-109M	$-111M	$-88M

Profitabilitas 7

Metrik	2025	2024	2023	2022	2021
Operating Margin	-320.5%	-336.1%	-669.8%	-416.6%	·
Net Margin	-292.1%	-296.0%	-638.3%	-412.2%	·
Pretax Margin	-291.7%	-295.6%	-632.2%	·	·
EBITDA Margin	-320.5%	-336.1%	-669.8%	-416.6%	·
ROA	-29.6%	-29.0%	-32.8%	-27.3%	-18.5%
ROE	-48.8%	-45.9%	-57.3%	-42.2%	-21.3%
ROIC	-45.0%	-55.5%	-57.0%	·	·

Likuiditas & Solvabilitas 4

Metrik	2025	2024	2023	2022	2021
Current Ratio	7.8	5.7	6.3	6.5	6.4
Quick Ratio	2.3	1.3	3.2	0.7	6.1
Debt / Equity	·	·	0.0	0.0	0.0
LT Debt / Equity	·	·	0.0	0.0	0.0

Efisiensi 2

Metrik	Tren	2025	2024	2023	2022	2021
Asset Turnover		0.1	0.1	0.1	0.1	·
Receivables Turnover		13.1	4.8	3.1	8.7	·

Per Saham 5

Metrik	2025	2024	2023	2022	2021
Book Value / Share	$2.65	$3.06	$4.07	$5.91	$8.00
Revenue / Share	$0.43	$0.51	$0.42	$0.64	·
Cash Flow / Share	$-1.19	$-0.94	$-2.15	$-2.17	·
Cash / Share	$0.77	$0.79	$2.09	$0.61	$1.56
EPS (TTM)	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82

Tingkat Pertumbuhan 2

Metrik	Tren	2025	2024	2023	2022	2021
Revenue YoY		1.0%	71.4%	-33.2%	-32.1%	·
Revenue CAGR 3Y		5.0%	-8.1%	·	·	·

Valuasi (TTM) 14

Metrik	2025	2024	2023	2022	2021
Revenue TTM	$36M	$36M	$21M	$31M	$46M
Net Income TTM	$-105M	$-105M	$-132M	$-128M	$-84M
Market Cap	$185M	$254M	$342M	$289M	$1.57B
Enterprise Value	·	·	$215M	$271M	$1.27B
P/E	-1.5	-2.4	-2.1	-2.3	-17.7
P/S	5.1	7.1	16.5	9.3	34.2
P/B	0.7	1.2	1.4	1.0	4.0
P / Tangible Book	0.7	1.2	1.4	1.0	4.0
P / Cash Flow	-1.9	-3.9	-3.2	-2.7	-18.0
P / FCF	-1.9	-3.9	-3.1	-2.6	-17.8
EV / EBITDA	·	·	-1.5	-2.1	-15.5
EV / FCF	·	·	-2.0	-2.4	-14.4
EV / Revenue	·	·	10.4	8.7	27.7
Earnings Yield	-66.5%	-42.2%	-47.3%	-44.4%	-5.7%

Laporan Laba Rugi 14

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$7M	$6M	$11M	$11M	$6M	$7M	$5M	$15M	$12M	$3M	$3M	$11M	$3M	$4M	$3M	$7M
R&D Expense	$24M	$25M	$25M	$26M	$26M	$27M	$33M	$32M	$24M	$23M	$30M	$28M	$30M	$29M	$31M	$30M
SG&A Expense	$9M	$9M	$9M	$9M	$9M	$9M	$10M	$12M	$10M	$10M	$10M	$11M	$10M	$11M	$10M	$10M
Operating Expenses	$33M	$34M	$34M	$46M	$35M	$36M	$43M	$44M	$33M	$35M	$41M	$39M	$40M	$40M	$41M	$39M
Operating Income	$-26M	$-28M	$-23M	$-34M	$-29M	$-29M	$-38M	$-28M	$-21M	$-32M	$-37M	$-28M	$-38M	$-36M	$-38M	$-32M
Other Non-op	$3M	$3M	$3M	$2M	$2M	$3M	$3M	$4M	$4M	$4M	$3M	$2M	$2M	$1M	$1M	$530.0K
Pretax Income	·	·	$-20M	$-32M	$-26M	$-26M	$-34M	$-25M	$-18M	$-28M	$-34M	$-26M	$-36M	$-35M	$-37M	$-32M
Income Tax	$0	$0	$121.0K	$0	$0	$0	$131.0K	$0	$0	$0	$277.0K	$1M	$0	$0	$0	$0
Net Income	$-24M	$-25M	$-20M	$-32M	$-26M	$-26M	$-35M	$-25M	$-18M	$-28M	$-35M	$-27M	$-36M	$-35M	$-37M	$-32M
EPS (Basic)	$-0.18	$-0.20	$-0.09	$-0.44	$-0.37	$-0.37	$-0.50	$-0.35	$-0.26	$-0.41	$-0.68	$-0.55	$-0.73	$-0.71	$-0.76	$-0.65
EPS (Diluted)	$-0.18	$-0.20	$-0.09	$-0.44	$-0.37	$-0.37	$-0.50	$-0.35	$-0.26	$-0.41	$-0.68	$-0.55	$-0.73	$-0.71	$-0.76	$-0.65
Shares (Basic)	130,696,742	126,074,555	·	72,563,311	71,005,743	70,833,044	·	69,627,190	68,810,259	68,432,168	·	49,212,126	49,063,631	49,032,319	·	48,921,928
Shares (Diluted)	130,696,742	126,074,555	·	72,563,311	71,005,743	70,833,044	·	69,627,190	68,810,259	68,432,168	·	49,212,126	49,063,631	49,032,319	·	48,921,928
EBITDA	$-26M	$-27M	·	$-34M	$-29M	$-29M	·	$-28M	$-21M	$-32M	·	$-28M	$-38M	$-36M	·	$-32M

Neraca 22

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$79M	$61M	$75M	$59M	$78M	$51M	$55M	$60M	$73M	$90M	$127M	$61M	$45M	$49M	$30M	$50M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$264M
Receivables	$1M	$3M	$2M	$7M	$2M	$8M	$3M	$10M	$1M	$14M	$12M	$500.0K	$1M	$528.0K	$1M	$1M
Prepaid Expense	$8M	$7M	$7M	$8M	$8M	$9M	$10M	$7M	$11M	$8M	$6M	$7M	$6M	$8M	$10M	$10M
Current Assets	$263M	$245M	$258M	$207M	$225M	$233M	$258M	$273M	$276M	$280M	$271M	$224M	$274M	$278M	$288M	$325M
PP&E (Net)	$4M	$4M	$5M	$5M	$6M	$5M	$6M	$6M	$7M	$7M	$7M	$7M	$8M	$8M	$7M	$7M
PP&E (Gross)	$16M	$16M	$16M	$16M	$16M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$15M	$16M	$16M	$15M
Accum. Depreciation	$11M	$11M	$11M	$10M	$10M	$10M	$9M	$9M	$9M	$8M	$8M	$8M	$8M	$9M	$8M	$8M
Other Non-current Assets	$4M	$4M	$4M	$211.0K	$178.0K	$3M	$3M	$5M	$3M	$5M	$3M	$3M	$3M	$3M	$2M	$1M
Total Assets	$359M	$329M	$359M	$265M	$297M	$320M	$350M	$376M	$381M	$398M	$376M	$333M	$375M	$396M	$431M	$461M
Accounts Payable	$1M	$773.0K	$858.0K	$1M	$2M	$683.0K	$1M	$2M	$913.0K	$2M	$1M	$1M	$2M	$1M	$1M	$2M
Current Liabilities	$48M	$27M	$33M	$36M	$44M	$41M	$45M	$43M	$54M	$55M	$43M	$30M	$48M	$39M	$45M	$45M
Capital Leases	$50M	$52M	$54M	$55M	$57M	$58M	$60M	$61M	$63M	$64M	$66M	$67M	$68M	$70M	$71M	$72M
Total Liabilities	$112M	$95M	$102M	$111M	$122M	$124M	$134M	$133M	$134M	$140M	$130M	$117M	$141M	$134M	$142M	$143M
Long-term Debt	·	·	·	·	·	·	·	·	·	·	·	$0	$10M	$12M	$11M	$11M
Total Debt	·	·	·	·	·	·	·	·	·	·	·	·	·	$11M	·	$11M
Common Stock	$12.0K	$10.0K	$9.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$7.0K	$6.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K
Retained Earnings	$-787M	$-764M	$-739M	$-718M	$-686M	$-660M	$-634M	$-599M	$-574M	$-557M	$-528M	$-494M	$-467M	$-431M	$-396M	$-359M
AOCI	$-444.0K	$-322.0K	$50.0K	$87.0K	$-30.0K	$43.0K	$53.0K	$455.0K	$-440.0K	$-380.0K	$-127.0K	$-904.0K	$-2M	$-2M	$-4M	$-5M
Stockholders' Equity	$247M	$234M	$257M	$154M	$174M	$195M	$216M	$243M	$247M	$258M	$246M	$216M	$234M	$262M	$289M	$318M
Liabilities + Equity	$359M	$329M	$359M	$265M	$297M	$320M	$350M	$376M	$381M	$398M	$376M	$333M	$375M	$396M	$431M	$461M
Shares Outstanding	122,905,756	104,036,350	96,914,418	74,174,515	71,007,083	70,989,661	70,625,899	70,562,901	68,815,642	68,778,591	60,467,188	49,259,870	49,065,098	49,052,509	48,966,216	48,951,283

Arus Kas 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$292.0K	$404.0K	·	$460.0K	$615.0K	$456.0K	·	$442.0K	$448.0K	$448.0K	·	$447.0K	·	·	·	·
Stock-based Comp	$3M	$3M	$4M	$5M	$5M	$6M	$8M	$9M	$6M	$6M	$6M	$8M	$6M	$6M	$7M	$6M
Other Non-cash	·	$-8M	·	·	·	$-13M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-2M	$-30M	$-22M	$-31M	$-12M	$-33M	$-18M	$-24M	$-5M	$-18M	$-24M	$-31M	$-19M	$-33M	$-29M	$-28M
CapEx	$37.0K	$64.0K	$11.0K	$411.0K	$185.0K	$0	$-4.0K	$-13.0K	$197.0K	$0	$157.0K	$600.0K	$362.0K	$589.0K	$1M	$3M
Investing Cash Flow	$-15M	$16M	$-81M	$4M	$39M	$29M	$14M	$162.0K	$-12M	$-53M	$32M	$58M	$15M	$54M	$9M	$20M
Stock Repurchased	$0	$200.0K	$14.0K	$24.0K	$0	$155.0K	$0	$85.0K	$0	$109.0K	$0	$16.0K	$0	$94.0K	$0	$0
Net Stock Activity	·	$-200.0K	·	·	·	$-155.0K	·	·	·	$-109.0K	·	·	·	$-94.0K	·	·
Financing Cash Flow	$34M	$462.0K	$119M	$8M	$0	$-46.0K	$112.0K	$11M	$135.0K	$35M	$58M	$-11M	$-746.0K	$-684.0K	$47.0K	$361.0K
Net Change in Cash	$17M	$-13M	$16M	$-19M	$27M	$-4M	$-4M	$-13M	$-17M	$-37M	$66M	$16M	$-5M	$20M	$-20M	$-8M
Free Cash Flow	·	$-30M	·	·	·	·	·	·	·	$-18M	·	·	·	$-34M	·	·

Profitabilitas 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-397.9%	-451.6%	·	-306.4%	-441.0%	-402.9%	·	-183.9%	-178.6%	-1060.2%	·	-251.2%	-1410.2%	-963.8%	·	-481.0%
Net Margin	-355.9%	-408.5%	·	-286.4%	-402.6%	-363.7%	·	-160.6%	-147.6%	-933.2%	·	-244.2%	-1348.4%	-925.2%	·	-473.2%
Pretax Margin	·	·	·	-286.4%	-402.6%	-363.7%	·	-160.6%	-147.6%	-933.2%	·	-235.1%	·	·	·	·
EBITDA Margin	-397.9%	-445.1%	·	-306.4%	-441.0%	-396.6%	·	-183.9%	-178.6%	-1060.2%	·	-251.2%	-1410.2%	-963.8%	·	-481.0%
ROA	-7.2%	-7.8%	·	-8.8%	-6.6%	-7.6%	·	·	·	-7.8%	·	·	·	-7.6%	·	-6.6%
ROE	-11.2%	-11.7%	·	-13.6%	-10.0%	-12.0%	·	·	·	-12.0%	·	·	·	-11.1%	·	-8.9%
ROIC	·	·	·	-22.3%	·	-14.9%	·	·	·	-12.5%	·	·	·	·	·	·

Likuiditas & Solvabilitas 4

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	5.4	9.0	·	5.8	5.1	5.7	·	·	·	5.1	·	·	·	7.1	·	7.2
Quick Ratio	1.7	2.4	·	1.8	1.8	1.5	·	·	·	1.9	·	·	·	1.3	·	7.0
Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	·	0.0
LT Debt / Equity	·	·	·	·	·	·	·	·	·	·	·	·	·	0.0	·	0.0

Efisiensi 2

Metrik	Tren	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	0.0	·	0.0	0.0	0.0	·	·	·	0.0	·	·	·	0.0	·	0.0
Receivables Turnover		3.8	1.1	·	2.8	3.3	0.8	·	·	·	0.4	·	·	·	3.3	·	2.1

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$2.01	$2.25	·	$2.08	$2.45	$2.75	·	·	·	$3.76	·	·	·	$5.35	·	$6.50
Revenue / Share	$0.05	$0.05	·	$0.15	$0.09	$0.10	·	$0.22	$0.17	$0.04	·	$0.23	$0.05	$0.08	·	$0.14
Cash Flow / Share	·	$-0.24	·	·	·	$-0.47	·	·	·	$-0.26	·	·	·	$-0.68	·	·
Cash / Share	$0.64	$0.59	·	$0.79	$1.10	$0.72	·	·	·	$1.30	·	·	·	$1.01	·	$1.01
EPS (TTM)	$-0.91	$-1.10	·	$-1.68	$-1.59	$-1.48	·	$-1.70	$-1.90	$-2.37	·	$-2.75	$-2.85	$-2.68	·	$-2.17

Valuasi (TTM) 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$35M	$35M	·	$30M	$34M	$40M	·	$34M	$29M	$20M	·	$20M	$16M	$27M	·	$48M
Net Income TTM	$-101M	$-104M	·	$-119M	$-112M	$-103M	·	$-105M	$-108M	$-126M	·	$-135M	$-140M	$-131M	·	$-107M
Market Cap	$574M	$274M	·	$165M	$102M	$114M	·	·	·	$562M	·	·	·	$154M	·	$429M
Enterprise Value	·	·	·	·	·	·	·	·	·	·	·	·	·	$115M	·	$127M
P/E	-5.1	-2.4	·	-1.3	-0.9	-1.1	·	-3.4	-2.4	-3.4	·	-0.7	-1.0	-1.2	·	-4.0
P/S	16.4	7.8	·	5.5	3.0	2.9	·	·	10.8	28.0	·	4.5	8.4	5.7	·	8.9
P/B	2.3	1.2	·	1.1	0.6	0.6	·	·	·	2.2	·	·	·	0.6	·	1.3
P / Tangible Book	2.3	1.2	·	1.1	0.6	0.6	·	·	·	2.2	·	·	·	0.6	·	1.3
P / Cash Flow	·	-9.1	·	·	·	-3.4	·	·	·	-31.0	·	·	·	-4.6	·	·
EV / Revenue	·	·	·	·	·	·	·	·	·	·	·	1.5	6.3	4.2	·	2.6
Earnings Yield	-19.5%	-41.8%	·	-75.7%	-111.2%	-92.5%	·	-29.8%	-41.1%	-29.0%	·	-147.8%	-103.6%	-85.4%	·	-24.7%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$36M	$36M	$21M	$31M	$46M
Margin Operasi %	-320.5%	-336.1%	-669.8%	-416.6%	·
Laba Bersih	$-105M	$-105M	$-132M	$-128M	$-84M
EPS Dilusian	$-1.27	$-1.52	$-2.67	$-2.62	$-1.82

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utang / Ekuitas	·	·	0.0	0.0	0.0
Rasio Lancar	7.8	5.7	6.3	6.5	6.4
Rasio Cepat	2.3	1.3	3.2	0.7	6.1

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$-99M	$-65M	$-109M	$-111M	$-88M

Pemilik institusional (13F) 162 pengaju · $544.7M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 162

Nilai yang dipegang $544.7M

Posisi baru 55

Posisi yang keluar 25

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
55 (+18 vs Kuartal sebelumnya)	25 (+16 vs Kuartal sebelumnya)	54 (+11 vs Kuartal sebelumnya)	30 (+1 vs Kuartal sebelumnya)	+30.8M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
MORGAN STANLEY	$41.410.468	8.867.338	7,60%	Saham
RA CAPITAL MANAGEMENT, L.P.	$37.360.000	8.000.000	6,86%	Saham
BlackRock, Inc.	$36.877.672	7.896.718	6,77%	Saham
Lynx1 Capital Management LP	$34.215.647	7.326.691	6,28%	Saham
Squadron Capital Management LLC	$33.624.000	7.200.000	6,17%	Saham
Bain Capital Life Sciences Investors, LLC	$33.492.820	7.171.910	6,15%	Saham
JPMORGAN CHASE & CO	$20.651.295	4.747.424	3,79%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$20.630.804	4.417.731	3,79%	Saham
CITADEL ADVISORS LLC	$19.555.999	4.187.580	3,59%	Saham
GOLDMAN SACHS GROUP INC	$16.489.728	3.530.991	3,03%	Saham
TWO SIGMA INVESTMENTS, LP	$16.203.532	3.469.707	2,97%	Saham
Soleus Capital Management, L.P.	$15.775.171	3.377.981	2,90%	Saham
SILVERARC CAPITAL MANAGEMENT, LLC	$14.159.720	3.032.060	2,60%	Saham
BANK OF AMERICA CORP /DE/	$12.405.197	2.656.359	2,28%	Saham
GEODE CAPITAL MANAGEMENT, LLC	$11.780.697	2.522.163	2,16%	Saham
Ikarian Capital, LLC	$11.362.110	2.433.000	2,09%	Saham
STATE STREET CORP	$9.879.950	2.115.621	1,81%	Saham
Candriam S.C.A.	$8.383.622	1.796.937	1,54%	Saham
VANGUARD GROUP INC	$8.365.446	4.379.815	1,54%	Saham
D. E. Shaw & Co., Inc.	$8.130.419	1.740.989	1,49%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$8.089.421	1.732.210	1,49%	Saham
WASATCH ADVISORS LP	$7.789.431	2.961.761	1,43%	Saham
Patient Square Capital LP	$7.513.166	1.608.815	1,38%	Saham
HighVista Strategies LLC	$6.295.800	1.348.136	1,16%	Saham
RENAISSANCE TECHNOLOGIES LLC	$5.556.497	1.189.828	1,02%	Saham
DIMENSIONAL FUND ADVISORS LP	$5.546.166	1.188.507	1,02%	Saham
NORTHERN TRUST CORP	$5.419.754	1.160.547	0,99%	Saham
CONGRESS ASSET MANAGEMENT CO	$4.686.051	1.003.437	0,86%	Saham
FMR LLC	$4.175.231	894.054	0,77%	Saham
UBS Group AG	$3.871.289	828.970	0,71%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$3.647.550	781.060	0,67%	Saham
BOOTHBAY FUND MANAGEMENT, LLC	$3.438.666	736.331	0,63%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.176.039	680.094	0,58%	Saham
VANGUARD FIDUCIARY TRUST CO	$2.844.712	609.146	0,52%	Saham
ExodusPoint Capital Management, LP	$2.709.511	580.195	0,50%	Saham
Velan Capital Investment Management LP	$2.661.900	570.000	0,49%	Saham
STEMPOINT CAPITAL LP	$2.445.436	523.648	0,45%	Saham
Rockefeller Capital Management L.P.	$2.315.465	495.817	0,43%	Saham
Nuveen, LLC	$2.260.326	484.010	0,41%	Saham
WELLS FARGO & COMPANY/MN	$2.114.113	452.701	0,39%	Saham
TWO SIGMA ADVISERS, LP	$2.040.262	1.068.200	0,37%	Saham
Man Group plc	$1.908.386	408.648	0,35%	Saham
Squadron Capital Management LLC	$1.868.000	400.000	0,34%	Opsi beli
PLATINUM INVESTMENT MANAGEMENT LTD	$1.796.857	384.766	0,33%	Saham
Seven Fleet Capital Management LP	$1.780.059	381.169	0,33%	Saham
Qube Research & Technologies Ltd	$1.730.487	370.554	0,32%	Saham
Atom Investors LP	$1.701.519	364.351	0,31%	Saham
Susquehanna Portfolio Strategies, LLC	$1.564.819	335.079	0,29%	Saham
ADAGE CAPITAL PARTNERS GP, L.L.C.	$1.517.750	325.000	0,28%	Saham
JANE STREET GROUP, LLC	$1.413.843	302.750	0,26%	Saham

Tampilkan semua 162 pemilik institusional →

Aktivis & pemilik 5%+ 1 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
Cobro Ventures Opportunity Fund, L.P., Cobro Opportunity Fund GP, LLC, Marc Cohen, Alain Cohen, Todd Kaloudis ×2 pengajuan	15 Juni 2021	·	Pengajuan awal	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 27 orang dalam · 13 pejabat · 15 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Jual 12m	Bersih 12m
Andrew Hirsch	President & CEO	15 Feb. 2026 F	1.074.934	0	$0
Kendra Adams	Chief Financial Officer	18 Sep. 2026 F	382.323	0	$0
Lauren White	Chief Financial Officer	30 Agu 2023 M	32.686	0	$0
William Mckee	Chief Financial Officer	6 Okt. 2020 P	5.263	0	$0
Leonard Reyno	Chief Medical Officer	10 Juli 2026 F	372.406	1	$-22.200
Paige Mahaney	Chief Scientific Officer	14 Feb. 2026 F	336.910	0	$0
Mark Mossler	Chief Accounting Officer	14 Feb. 2026 F	71.916	0	$0
Scott N Boyle	Chief Business Officer	14 Feb. 2026 F	298.801	0	$0
Kelly Schick	Chief People Officer	14 Feb. 2026 F	299.881	0	$0
Jolie Siegel	Chief Legal Officer	14 Feb. 2025 A	107.939	0	$0
Stewart Fisher	Chief Scientific Officer	16 Sep. 2024 M	130.710	0	$0
Adam Crystal	Chief Medical Officer	30 Jan. 2023 M	20.097	0	$0
Laura Jean Wahlberg	VP of Finance Corp Controller	11 Feb. 2021 A	·	0	$0
Kenneth Carl Anderson	Direktur	1 Okt. 2026 A	75.612	0	$0
Donna Roy Grogan	Direktur	1 Okt. 2026 A	79.471	0	$0
Stephen Fawell	Direktur	24 Juni 2026 A	·	0	$0
Laura Bessen	Direktur	24 Juni 2026 A	·	0	$0
Utpal Koppikar	Direktur	24 Juni 2026 A	5.667	0	$0
Ronald Harold Wilfred Cooper	Direktur	24 Juni 2026 A	·	0	$0
Owen Hughes	Direktur	24 Juni 2026 A	·	0	$0
Steven L. Hoerter	Direktur	24 Juni 2026 A	·	0	$0
Malcolm Salter	Direktur	20 Juni 2024 A	11.380	0	$0
Bruce Downey	Direktur	20 Juni 2024 A	489.542	0	$0
Glenn Dubin	Direktur	1 April 2024 A	22.075	0	$0
Marc A Cohen	Direktur	22 Juni 2022 A	1.118	0	$0
Alain J Cohen	Direktur	4 April 2022 A	928	0	$0
Elena Prokupets	Direktur	27 Sep. 2021 S	503.126	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 20 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
QQQS · Invesco Exchange-Traded Fund Trust …	0,46%	32.308 SH	1 Okt. 2026	Harian
IWC · iShares Trust	0,08%	342.369 SH	11 Sep. 2026	Harian
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	88.122 SH	19 Agu 2026	Harian
IBB · iShares Trust	0,03%	845.464 SH	11 Sep. 2026	Harian
PRFZ · Invesco Exchange-Traded Fund Trust	0,03%	222.078 SH	1 Okt. 2026	Harian
IBBQ · Invesco Exchange-Traded Fund Trust …	0,03%	8.690 SH	1 Okt. 2026	Harian
IWM · iShares Trust	0,01%	2.614.567 SH	11 Sep. 2026	Harian
RSSL · Global X Funds	0,01%	48.213 NS	31 Juli 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	583.446 SH	19 Agu 2026	Harian
DFAS · Dimensional ETF Trust	0,01%	235.215 NS	31 Juli 2026	N-PORT
DXUV · Dimensional ETF Trust	0,00%	3.906 NS	31 Juli 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	14.611 NS	31 Juli 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	8.504 NS	31 Juli 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	115.180 NS	31 Juli 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	19.202 NS	31 Juli 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	21.036 NS	31 Juli 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	1.046.993 SH	19 Agu 2026	Harian
VTI · VANGUARD INDEX FUNDS	0,00%	3.264.924 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	8.526 SH	19 Agu 2026	Harian
IWN · iShares Trust	·	926.223 SH	11 Sep. 2026	Harian

CCCC Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 13 analis BELI

Target median $11.00 +272,9%

4 30,8% Beli Kuat

8 61,5% Beli

1 7,7% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

6 analis · 2026-09-30

Target rata-rata $13.33 +352,0%

← Di bawah semua target Harga saat ini $2.95

Rendah$7.00 Rata-rata$13.33 Tinggi$30.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
CCCC	$185M	-1.5	1.0%	-292.1%	-48.8%	·
MYGN	$575M	-1.6	-1.6%	-44.4%	-96.8%	69.9%
RZLT	$501M	-6.9	·	·	-67.8%	·
KYTX	$568M	-2.6	·	·	-77.4%	·
SPRY	$1.16B	-6.7	-5.5%	-203.3%	-111.8%	·
EIKN	·	·	·	·	·	·
EDIT	$201M	-1.1	25.4%	-395.0%	-688.8%	·
GALT	$271M	-8.7	·	·	25.0%	·
IRD	$140M	-2.5	29.1%	-349.3%	-302.2%	·
AGEN	$111M	·	10.4%	-2.7%	1.0%	·

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

CCCC C4 Therapeutics, Inc. - Common Stock